Literature DB >> 25303873

Lentivirus-mediated silencing of SCIN inhibits proliferation of human lung carcinoma cells.

Hongxu Liu1, Daiwang Shi2, Tieqin Liu2, Zhanwu Yu3, Chuanjiang Zhou4.   

Abstract

SCIN (scinderin) is a calcium-dependent actin severing and capping protein. Homologue in zebrafish has been found to be related with cell death. In the present study, we found that SCIN is highly expressed in human lung cancer specimens. However, the role of SCIN in lung cancer has not yet been determined. To investigate the function of SCIN in lung carcinoma cells, we took advantage of lentivirus-mediated RNA interference (RNAi) to knockdown SCIN expression in two lung carcinoma cell lines A549 and H1299. Silencing of SCIN significantly inhibited the proliferation and colony formation ability of both cell lines in vitro. Moreover, flow cytometry analysis showed that knockdown of SCIN led to G0/G1 phase cell cycle arrest as well as an excess accumulation of cells in the sub-G1 phase. Furthermore, depletion of SCIN resulted in a significant increase in Cyclin B1, p21 and PARP expression, and a little decrease in Cyclin D1 expression. These results suggest that SCIN plays an important role in lung carcinoma cell proliferation, and lentivirus-mediated silencing of SCIN might be a potential therapeutic approach for the treatment of lung cancer.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Lentivirus; Lung carcinoma; Proliferation; RNAi; SCIN

Mesh:

Substances:

Year:  2014        PMID: 25303873     DOI: 10.1016/j.gene.2014.10.013

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  9 in total

1.  Scinderin-knockdown inhibits proliferation and promotes apoptosis in human breast carcinoma cells.

Authors:  Wenjing Jian; Xiaoli Zhang; Jiguo Wang; Yunlong Liu; Chuting Hu; Xianming Wang; Renbin Liu
Journal:  Oncol Lett       Date:  2018-06-21       Impact factor: 2.967

2.  Scinderin is a novel transcriptional target of BRMS1 involved in regulation of hepatocellular carcinoma cell apoptosis.

Authors:  Xiaojing Qiao; Yiren Zhou; Wenjuan Xie; Yi Wang; Yicheng Zhang; Tian Tian; Jianming Dou; Xi Yang; Suqin Shen; Jianwei Hu; Shouyi Qiao; Yanhua Wu
Journal:  Am J Cancer Res       Date:  2018-06-01       Impact factor: 6.166

3.  Scinderin suppresses cell proliferation and predicts the poor prognosis of hepatocellular carcinoma.

Authors:  Bin Zhou; Tian-Wei Chen; Ya-Bo Jiang; Xu-Biao Wei; Chong-De Lu; Jing-Jing Li; Dong Xie; Shu-Qun Cheng
Journal:  Oncol Lett       Date:  2020-01-08       Impact factor: 2.967

4.  Scinderin promotes the invasion and metastasis of gastric cancer cells and predicts the outcome of patients.

Authors:  Jia-Jia Liu; Jun-Yan Liu; Jun Chen; Yi-Xi Wu; Peng Yan; Cheng-Dong Ji; Yan-Xia Wang; Dong-Fang Xiang; Xia Zhang; Peng Zhang; You-Hong Cui; Ji Ming Wang; Xiu-Wu Bian; Feng Qian
Journal:  Cancer Lett       Date:  2016-03-24       Impact factor: 8.679

5.  Effect of prostaglandin reductase 1 (PTGR1) on gastric carcinoma using lentivirus-mediated system.

Authors:  Shuo Yang; Fen Luo; Jun Wang; Xiang Mao; Zongyou Chen; Zhiming Wang; Fenghua Guo
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

6.  Aberrant Scinderin Expression Correlates With Liver Metastasis and Poor Prognosis in Colorectal Cancer.

Authors:  Qi Lin; Jun Li; Dexiang Zhu; Zhengchuan Niu; Xiangou Pan; Pingping Xu; Meiling Ji; Ye Wei; Jianmin Xu
Journal:  Front Pharmacol       Date:  2019-10-31       Impact factor: 5.810

7.  Calcium-controlled conformational choreography in the N-terminal half of adseverin.

Authors:  Sakesit Chumnarnsilpa; Robert C Robinson; Jonathan M Grimes; Cedric Leyrat
Journal:  Nat Commun       Date:  2015-09-14       Impact factor: 14.919

8.  Loss of scinderin decreased expression of epidermal growth factor receptor and promoted apoptosis of castration-resistant prostate cancer cells.

Authors:  Xiaofeng Lai; Weipeng Su; Hu Zhao; Shunliang Yang; Tengyue Zeng; Weizhen Wu; Dong Wang
Journal:  FEBS Open Bio       Date:  2018-04-10       Impact factor: 2.693

9.  A proteomic analysis of an in vitro knock-out of miR-200c.

Authors:  Bojan Ljepoja; Jonathan García-Roman; Ann-Katrin Sommer; Thomas Fröhlich; Georg J Arnold; Ernst Wagner; Andreas Roidl
Journal:  Sci Rep       Date:  2018-05-02       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.